Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer-Reference-Cited by-同舟云学术

Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer

Published:2006-03-01 Issue:4 Volume:66 Page:439-444
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Kaku Haruki,Saika Takashi,Tsushima Tomoyasu,Ebara Shin,Senoh Takashi,Yamato Toyoko,Nasu Yasutomo,Kumon Hiromi

Publisher

Wiley

Subject

Urology,Oncology

Reference15 articles.

1. Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

2. Intermittent androgen suppression in the treatment of prostate cancer: A preliminary report

3. Intermittent androgen suppression in the management of prostate cancer

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis;Advances in Therapy;2024-08-21

2. Impact of neoadjuvant relugolix on patient-reported sexual function and bother;Frontiers in Oncology;2024-04-11

3. Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study;European Urology;2023-12

4. Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study;European Urology Oncology;2023-12

5. New perspectives in functional hypogonadotropic hypogonadism: beyond late onset hypogonadism;Frontiers in Endocrinology;2023-06-29